2008 - The Walter E. Stamm Mentor Award, Infectious Diseases Society of America
Member of the Association of American Physicians
His primary areas of study are Amphotericin B, Microbiology, Antibiotics, Immunology and Candida albicans. His work carried out in the field of Amphotericin B brings together such families of science as Aspergillus fumigatus, Hemolysis, Filipin and Pharmacology. Many of his research projects under Microbiology are closely connected to Communication with Communication, tying the diverse disciplines of science together.
He interconnects Vancomycin and Formulary in the investigation of issues within Antibiotics. His Immunology research incorporates elements of Flucytosine, Nausea and Ketoconazole. His research in Candida albicans focuses on subjects like Ergosterol, which are connected to Membrane, Cholesterol and Catalase.
Gerald Medoff mainly focuses on Amphotericin B, Microbiology, Antibiotics, Biochemistry and Pharmacology. His study looks at the relationship between Amphotericin B and fields such as Polyene, as well as how they intersect with chemical problems. As part of the same scientific family, Gerald Medoff usually focuses on Microbiology, concentrating on Yeast and intersecting with Histoplasma, Virulence and Intracellular.
His Antibiotics study frequently draws connections between related disciplines such as Filipin. His study in Biochemistry is interdisciplinary in nature, drawing from both Molecular biology and Candida albicans. His Pharmacology research integrates issues from Lomustine, Nitrosourea, Leukemia, Cytotoxicity and Carmustine.
The scientist’s investigation covers issues in Intensive care medicine, Pharmacology, Family medicine, Pediatrics and Microbiology. The concepts of his Intensive care medicine study are interwoven with issues in Toxicity, Formulary, Antimicrobial and Antibiotic use. His research investigates the connection with Pharmacology and areas like Fluconazole which intersect with concerns in Drug, Drug resistance, Itraconazole, Bioinformatics and Chemotherapy.
His Pediatrics research is multidisciplinary, incorporating elements of Incidence and Candida krusei, Candida tropicalis. Gerald Medoff has included themes like Sepsis and Bacteria in his Microbiology study. His studies link Amphotericin B with Aspergillus.
Pediatrics, Microbiology, Infection control, Epidemiology and Hospitalized patients are his primary areas of study. His studies deal with areas such as Candida parapsilosis, Incidence and Candida krusei, Candida tropicalis as well as Pediatrics. His work in the fields of Microbiology, such as Microbial disease, overlaps with other areas such as Communication.
His biological study spans a wide range of topics, including Intensive care and Emergency medicine. His research in Epidemiology intersects with topics in Antibacterial agent, Antibiotic use, Intensive care medicine and Positive blood culture, Blood culture. While working in this field, Gerald Medoff studies both Hospitalized patients and Retrospective review.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of Mortality
V J Fraser;M Jones;J Dunkel;S Storfer.
Clinical Infectious Diseases (1992)
Amphotericin B: current understanding of mechanisms of action.
J Brajtburg;W G Powderly;G S Kobayashi;G Medoff.
Antimicrobial Agents and Chemotherapy (1990)
Strategies in the treatment of systemic fungal infections.
Gerald Medoff;George S. Kobayashi.
The New England Journal of Medicine (1980)
Amphotericin B-Induced Oxidative Damage and Killing of Candida albicans
Marcia L. Sokol-Anderson;Janina Brajtburg;Gerald Medoff.
The Journal of Infectious Diseases (1986)
Amphotericin B-resistant yeast infection in severely immunocompromised patients☆
William G. Powderly;George S. Kobayashi;Geoffrey P. Herzig;Gerald Medoff.
The American Journal of Medicine (1988)
Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients: National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study
William E. Dismukes;Alan M. Stamm;John R. Graybill;Philip C. Craven.
Annals of Internal Medicine (1983)
Antibiotic Synergism Against Listeria monocytogenes
Robert C. Moellering;Gerald Medoff;Irene Leech;Christine Wennersten.
Antimicrobial Agents and Chemotherapy (1972)
Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine.
Victoria J. Fraser;Marilyn Jones;Patrick R. Murray;Gerald Medoff.
The American review of respiratory disease (1992)
Mechanisms of Microbial Disease
Moselio Schaechter;Gerald Medoff;David Schlessinger.
Classification of Polyene Antibiotics According to Chemical Structure and Biological Effects
J. Kotler-Brajtburg;G. Medoff;G. S. Kobayashi;S. Boggs.
Antimicrobial Agents and Chemotherapy (1979)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: